These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11742250)

  • 1. Lower dopamine transporter binding potential in striatum during depression.
    Meyer JH; Krüger S; Wilson AA; Christensen BK; Goulding VS; Schaffer A; Minifie C; Houle S; Hussey D; Kennedy SH
    Neuroreport; 2001 Dec; 12(18):4121-5. PubMed ID: 11742250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.
    Guttman M; Stewart D; Hussey D; Wilson A; Houle S; Kish S
    Neurology; 2001 Jun; 56(11):1559-64. PubMed ID: 11402115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder: In Vivo Positron Emission Tomography and Postmortem Evidence.
    Pizzagalli DA; Berretta S; Wooten D; Goer F; Pilobello KT; Kumar P; Murray L; Beltzer M; Boyer-Boiteau A; Alpert N; El Fakhri G; Mechawar N; Vitaliano G; Turecki G; Normandin M
    JAMA Psychiatry; 2019 Aug; 76(8):854-861. PubMed ID: 31042280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion occupancy of the dopamine transporter is low during clinical treatment.
    Meyer JH; Goulding VS; Wilson AA; Hussey D; Christensen BK; Houle S
    Psychopharmacology (Berl); 2002 Aug; 163(1):102-5. PubMed ID: 12185406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated midbrain serotonin transporter availability in mixed mania: a case report.
    Tolmunen T; Joensuu M; Saarinen PI; Mussalo H; Ahola P; Vanninen R; Kuikka J; Tiihonen J; Lehtonen J
    BMC Psychiatry; 2004 Sep; 4():27. PubMed ID: 15363105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
    Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal dopamine transporter density in major depression.
    Laasonen-Balk T; Kuikka J; Viinamäki H; Husso-Saastamoinen M; Lehtonen J; Tiihonen J
    Psychopharmacology (Berl); 1999 Jun; 144(3):282-5. PubMed ID: 10435396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
    Fleckenstein AE; Pögün S; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):200-6. PubMed ID: 8858994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
    van Dyck CH; Malison RT; Jacobsen LK; Seibyl JP; Staley JK; Laruelle M; Baldwin RM; Innis RB; Gelernter J
    J Nucl Med; 2005 May; 46(5):745-51. PubMed ID: 15872345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine.
    Gatley SJ; Volkow ND; Fowler JS; Dewey SL; Logan J
    Synapse; 1995 Jun; 20(2):137-44. PubMed ID: 7570343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia.
    Yoder KK; Hutchins GD; Morris ED; Brashear A; Wang C; Shekhar A
    Schizophr Res; 2004 Dec; 71(2-3):371-5. PubMed ID: 15474908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine transporter availability in unmedicated bipolar disorder.
    Anand A; Barkay G; Dzemidzic M; Albrecht D; Karne H; Zheng QH; Hutchins GD; Normandin MD; Yoder KK
    Bipolar Disord; 2011 Jun; 13(4):406-13. PubMed ID: 21843280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia.
    Laakso A; Bergman J; Haaparanta M; Vilkman H; Solin O; Syvälahti E; Hietala J
    Schizophr Res; 2001 Oct; 52(1-2):115-20. PubMed ID: 11595398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.